A Study of CPI-0209 in Patients With Advanced Solid Tumors and Lymphomas Read more about A Study of CPI-0209 in Patients With Advanced Solid Tumors and Lymphomas
I-SPY COVID-19 TRIAL: An Adaptive Platform Trial for Critically Ill Patients Read more about I-SPY COVID-19 TRIAL: An Adaptive Platform Trial for Critically Ill Patients
Phase 2 Trial of MRTX849 Monotherapy and in Combination With Pembrolizumab for NSCLC With KRAS G12C Mutation KRYSTAL-7 Read more about Phase 2 Trial of MRTX849 Monotherapy and in Combination With Pembrolizumab for NSCLC With KRAS G12C Mutation KRYSTAL-7
Testing the Addition of a Type of Drug Called Immunotherapy to the Usual Chemotherapy Treatment for Non-small Cell Lung Cancer, ALCHEMIST Chemo-IO Study Read more about Testing the Addition of a Type of Drug Called Immunotherapy to the Usual Chemotherapy Treatment for Non-small Cell Lung Cancer, ALCHEMIST Chemo-IO Study
Registry of Asthma Patients Initiating DUPIXENT® Read more about Registry of Asthma Patients Initiating DUPIXENT®
Testing the Addition of the Pill Chemotherapy, Cabozantinib, to the Standard Immune Therapy Nivolumab Compared to Standard Chemotherapy for Non-small Cell Lung Cancer Read more about Testing the Addition of the Pill Chemotherapy, Cabozantinib, to the Standard Immune Therapy Nivolumab Compared to Standard Chemotherapy for Non-small Cell Lung Cancer
Study of Seribantumab in Adult Patients With NRG1 Gene Fusion Positive Advanced Solid Tumors Read more about Study of Seribantumab in Adult Patients With NRG1 Gene Fusion Positive Advanced Solid Tumors
ACTIV-3: Therapeutics for Inpatients With COVID-19 Read more about ACTIV-3: Therapeutics for Inpatients With COVID-19
Accelerating COVID-19 Therapeutic Interventions and Vaccines 4 ACUTE Read more about Accelerating COVID-19 Therapeutic Interventions and Vaccines 4 ACUTE
Testing the Combination of the Anti-cancer Drugs XL184 (Cabozantinib) and Nivolumab in Patients With Advanced Cancer and HIV Read more about Testing the Combination of the Anti-cancer Drugs XL184 (Cabozantinib) and Nivolumab in Patients With Advanced Cancer and HIV